MM-130: Tolerability and Efficacy of Daratumumab in Patients with Plasma Cell Disorder with Poor Performance Status or Good Performance Status with CKD and/or CHF

Clinical Lymphoma Myeloma and Leukemia(2020)

引用 0|浏览1
暂无评分
关键词
MM,multiple myeloma,plasma cell disorders,amyloidosis,daratumumab,poor performance status
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要